TY - JOUR
T1 - Are Periocular and Systemic Allergy Conditions Risk Factors for Pterygium?
AU - Eyni, Yotam
AU - Kerman, Tomer
AU - Hazan, Itai
AU - Rosenberg, Elli
AU - Lev Ari, Omer
AU - Knyazer, Boris
AU - Tsumi, Erez
N1 - Publisher Copyright:
© 2023 Taylor & Francis.
PY - 2023/1/1
Y1 - 2023/1/1
N2 - Purpose: To evaluate risk factors for pterygium and prevalence of periocular and systemic diseases among patients with pterygium. Methods: A retrospective case-control study was conducted among members of Clalit Health Services (CHS) in Israel, from 2001 to 2022. A total of 13,944 patients diagnosed with pterygium were included. For each case, three controls were matched among all CHS patients according to year of birth, sex, and ethnicity. Mixed models were used to assess differences in demographic characteristics, ocular and systemic diseases between the groups. Generalized estimating equation (GEE) logistic regression was used to estimate the odds ratios (OR) and adjust for confounders. Results: The average age of pterygium patients was 49 ± 17 years; 51% were male. The results showed significant associations between pterygium and risk factors of vernal kerato-conjunctivitis (OR 2.52, 95% confidence interval [CI]: [1.96–3.24]), chronic allergic conjunctivitis (OR 1.98, 95% CI: [1.65–2.39]), blepharitis (OR 1.91, 95% CI: [1.78–2.04]), chalazion (OR 1.47, 95% CI: [1.30–1.67]) and unspecified systemic allergy (OR 1.21, 95% CI [1.09–1.34]), after adjusting for rural residency status. Glaucoma (OR 0.74, 95% CI [0.64–0.85]) and smoking (OR 0.70, 95% CI [0.66–0.75]) were protective factors against pterygium. Conclusion: Systemic and periocular inflammatory and allergic diseases are risk factors for pterygium.
AB - Purpose: To evaluate risk factors for pterygium and prevalence of periocular and systemic diseases among patients with pterygium. Methods: A retrospective case-control study was conducted among members of Clalit Health Services (CHS) in Israel, from 2001 to 2022. A total of 13,944 patients diagnosed with pterygium were included. For each case, three controls were matched among all CHS patients according to year of birth, sex, and ethnicity. Mixed models were used to assess differences in demographic characteristics, ocular and systemic diseases between the groups. Generalized estimating equation (GEE) logistic regression was used to estimate the odds ratios (OR) and adjust for confounders. Results: The average age of pterygium patients was 49 ± 17 years; 51% were male. The results showed significant associations between pterygium and risk factors of vernal kerato-conjunctivitis (OR 2.52, 95% confidence interval [CI]: [1.96–3.24]), chronic allergic conjunctivitis (OR 1.98, 95% CI: [1.65–2.39]), blepharitis (OR 1.91, 95% CI: [1.78–2.04]), chalazion (OR 1.47, 95% CI: [1.30–1.67]) and unspecified systemic allergy (OR 1.21, 95% CI [1.09–1.34]), after adjusting for rural residency status. Glaucoma (OR 0.74, 95% CI [0.64–0.85]) and smoking (OR 0.70, 95% CI [0.66–0.75]) were protective factors against pterygium. Conclusion: Systemic and periocular inflammatory and allergic diseases are risk factors for pterygium.
KW - Allergy
KW - Pterygium
KW - Risk factors
KW - Vernal kerato-conjunctivitis
UR - http://www.scopus.com/inward/record.url?scp=85163134820&partnerID=8YFLogxK
U2 - 10.1080/08820538.2023.2223266
DO - 10.1080/08820538.2023.2223266
M3 - Review article
C2 - 37303165
AN - SCOPUS:85163134820
SN - 0882-0538
VL - 38
SP - 722
EP - 726
JO - Seminars in Ophthalmology
JF - Seminars in Ophthalmology
IS - 8
ER -